Literature DB >> 28103508

The mechanism of alopolysaccharide protecting ulceralive colitis.

Hu Lin1, Li Honglang2, Li Weifeng1, Chen Junmin1, Yang Jiantao1, Gu Junjing1.   

Abstract

The aim of this study is to explain the mechanism of alopolysaccharide protecting ulceralive colitis in cells and animal models. We divided this study into two parts: cell and animal research parts. In the cell research, HT-29 cells were divided into normal group, model group, aloe polysacchride group and positive drug group, the cell model was used by tumor necrosis factor- α (TNF-α) combine with LPS, detecting IL-6 concentration of difference groups by Elisa testing, Apoptosis of each group was detected by flow cytometry. We detected JAK2 and STAT-3 gene expressions of difference groups by RT-PCR. WB assay was used to detect the expression of JAK2, p-JAK2, STAT-3 and p-STAT3 protein in the cells of each group. In animal experiment, SD rats were divided into normal group, model control group, aloe polysaccharide group and positive drug group. A rat model of colitis was established with 2,4,6- three nitrobenzene sulfonic acid (TNBS). IL-6 concentrations of difference groups were measured by Elisa test, and compared the colon length of difference groups, H&E staining observation of colon tissue changes in each group. We observed JAK2, p-JAK2, STAT-3 and p-STAT3 protein expression in colon tissues by immuno histochemistry and measured JAK2 and STAT-3 gene expression of difference groups by RT-PCR. We found IL-6 concentration and cell apoptosis rate of Model group were significantly up-regulation compared with normal group (P<0.05, respectively) in the cell experiment. Compared with Model group, The IL-6 concentration and apoptosis rate of aloe polysaccharide group and positive drug group were significantly down-regulation (P<0.05, respectively). In the gene expression, JAK2 and STAT-3 expression of aloe polysaccharide group and positive drug group were higher than model group (P<0.05, respectively). JAK2, p-JAK2, STAT-3 and p-STAT3 protein expression of Aloe polysaccharide group and positive drug group were lower than model group. In animal experiment, compared with model group, The serum IL-6 concentration of aloe polysaccharide group and positive drug group were significantly decreased (P<0.05, respectively), colon length was improved by drug treated, The HE stain of aloe polysaccharide and positive drug group were significantly improved. In immuno histochemistry, The JAK2, p-JAK2, STAT-3 and p-STAT3 protein expression of aloe polysaccharide and positive drug group was significantly improved, The JAK2 and STAT-3 gene expression of aloe polysaccharide group and positive drug group were signivicantly lower than those of model group (P<0.05, respectively). Depending on the results, We supposed Aloe polysaccharide could effectively control the apoptosis of colonic tissues by inhibiting the JAK2/STAT-3 signaling pathway in vovo and vitro.
Copyright © 2016. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Aloe polysaccharide; Apoptosis; JAK2/STAT-3 signaling pathway; Ulcerative colitis

Mesh:

Substances:

Year:  2017        PMID: 28103508     DOI: 10.1016/j.biopha.2016.11.138

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  11 in total

1.  Mesenchymal stem cells-derived extracellular vesicles containing miR-378a-3p inhibit the occurrence of inflammatory bowel disease by targeting GATA2.

Authors:  Ping Li; Hai-Yan Zhang; Jian-Zhen Gao; Wen-Qiang Du; Dong Tang; Wei Wang; Liu-Hua Wang
Journal:  J Cell Mol Med       Date:  2022-05-17       Impact factor: 5.295

2.  Bryostatin-1 ameliorated experimental colitis in Il-10-/- Mice by protecting the intestinal barrier and limiting immune dysfunction.

Authors:  Lugen Zuo; Jing Li; Sitang Ge; Yuanyuan Ge; Mengdi Shen; Yan Wang; Changmin Zhou; Rong Wu; Jianguo Hu
Journal:  J Cell Mol Med       Date:  2019-06-28       Impact factor: 5.310

3.  Investigation of the Active Ingredients and Mechanism of Hudi Enteric-Coated Capsules in DSS-Induced Ulcerative Colitis Mice Based on Network Pharmacology and Experimental Verification.

Authors:  Panghua Ding; Jiajing Liu; Qiuyi Li; Qiongqiong Lu; Junxiang Li; Rui Shi; Lei Shi; Tangyou Mao; Dongyu Ge; HaiJun Niu; Guiying Peng; Zhibin Wang
Journal:  Drug Des Devel Ther       Date:  2021-10-08       Impact factor: 4.162

4.  Anti-Inflammatory, Antioxidant, and Healing-Promoting Effects of Aloe vera Extract in the Experimental Colitis in Rats.

Authors:  Mahvash Alizade Naini; Asal Zargari-Samadnejad; Shayan Mehrvarz; Romina Tanideh; Mohammad Ghorbani; Amirreza Dehghanian; Maryam Hasanzarrini; Farnaz Banaee; Omid Koohi-Hosseinabadi; Nader Tanideh; Aida Iraji
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-06       Impact factor: 2.629

Review 5.  Natural Products Modulate Cell Apoptosis: A Promising Way for the Treatment of Ulcerative Colitis.

Authors:  Chenhao Liu; Yiwei Zeng; Yulong Wen; Xinggui Huang; Yi Liu
Journal:  Front Pharmacol       Date:  2022-01-31       Impact factor: 5.810

6.  The potential application of natural products in cutaneous wound healing: A review of preclinical evidence.

Authors:  E Liu; Hongjin Gao; YiJia Zhao; Yaobing Pang; Yejing Yao; Zhengru Yang; Xueer Zhang; YanJin Wang; Siming Yang; Xiao Ma; Jinhao Zeng; Jing Guo
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

Review 7.  Molecular mechanisms and associated cell signalling pathways underlying the anticancer properties of phytochemical compounds from Aloe species (Review).

Authors:  Hanna Svitina; Josias H Hamman; Chrisna Gouws
Journal:  Exp Ther Med       Date:  2021-06-08       Impact factor: 2.447

8.  Huanglian Jiedu Decoction ameliorates DSS-induced colitis in mice via the JAK2/STAT3 signalling pathway.

Authors:  Zhuo Lu; Wanna Xiong; Simeng Xiao; Yilong Lin; Kai Yu; Guihua Yue; Qiaoming Liu; Fang Li; Jianqin Liang
Journal:  Chin Med       Date:  2020-05-08       Impact factor: 5.455

Review 9.  Pharmacological Update Properties of Aloe Vera and its Major Active Constituents.

Authors:  Marta Sánchez; Elena González-Burgos; Irene Iglesias; M Pilar Gómez-Serranillos
Journal:  Molecules       Date:  2020-03-13       Impact factor: 4.411

Review 10.  Herb-Drug Interaction in Inflammatory Diseases: Review of Phytomedicine and Herbal Supplements.

Authors:  Annemarie Lippert; Bertold Renner
Journal:  J Clin Med       Date:  2022-03-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.